In conclusion, blocking CD137 expression in T, NKT-like and NK cells is associated with downregulation of IFNγ, TNFα and granzyme B and may have novel therapeutic implications for patients with COPD where current strategies are inadequate. Here, GZMB is linked to chronic obstructive pulmonary disease.